TITLE

Consumer fears prompt J&J aloe vera wipe launch

AUTHOR(S)
Singh, Sonoo
PUB. DATE
June 2002
SOURCE
Marketing Week;6/13/2002, Vol. 25 Issue 24, p6
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports on the launch of a range of aloe vera baby wipes by Johnson & Johnson. Budget for advertising and marketing; Factor driving the launch; Aim of the product to capitalize on the growing popularity of the aloe vera plant; Retail price.
ACCESSION #
6867192

 

Related Articles

  • J&J extends teen appeal with skin care SKUs. GROSSMAN, ANDREW M. // Drug Store News;3/15/99, Vol. 21 Issue 5, p78 

    Provides information on new skin care products to be introduced by J&J's Clean & Clear brand in March 1999. Details on the nose and pore strips; Information on the Continuous Control Daily Cleanser.

  • J&J Gets More Face Time In Skin Care Category. Bittar, Christine // Brandweek;6/2/2003, Vol. 44 Issue 22, p9 

    Reports that Johnson & Johnson will launch skin-care products that are aimed at young adults and baby boomers in the U.S. as of June 2, 2003. Information on the two sub-brands under the Neutrogena line of products; Update on the product launches from Procter & Gamble (P&G), Unilever and L'Oreal...

  • Changes abound in tampon market. Sloan, Pat; Petrecca, Laura // Advertising Age;7/29/1996, Vol. 67 Issue 31, p6 

    The article reports that increasing competition in the tampon market has yielded a spate of new products and agency shifts in the U.S. in 1996. Key issues discussed include Tambrands' launch of its new Tampax Non-Applicator Naturals, Johnson and Johnson's introduction of a tampon with an...

  • G2, Zyrtec Top New Product Sales in '08. Wong, Elaine; Hein, Kenneth // Brandweek;3/23/2009, Vol. 50 Issue 12, p005 

    The article focuses on a report from Information Resources Inc. which was released in 2009. The report, which is concerned with food and nonfood product brands that have completed one full year of sales, have gained at least 30% national distribution in the U.S. and have generated at least $7.5...

  • TEST CASES: MARKETERS DABBLE IN DIAGNOSTICS. Neff, Jack // Advertising Age;10/22/2007, Vol. 78 Issue 42, p4 

    The article discusses the EarlyDetect DNA Paternity Home Collection Test Kit, which is billed as a painless and noninvasive way to test paternity. The product is one of many home diagnostics products that are creating a new health-care market. Other companies entering the market include Johnson...

  • Initial sales tally for J&J's Renova disappointing. Sloan, Pat; Wilke, Michael // Advertising Age;9/2/1996, Vol. 67 Issue 36, p4 

    The article reports on the market performance of Johnson and Johnson's Renova anti-wrinkle prescription skin cream in the United States since its launch in February 1996. Key issues discussed include the lower-than-expected sales for Renova and the possible reasons behind the slow sales of the...

  • IDEXX unveils 12-test individualized chemistry packages.  // DVM: The Newsmagazine of Veterinary Medicine;Jan2004 New Product Supplement, p14 

    IDEXX Laboratories Inc. has introduces convenient 12-test individual chemistry packages for the VetTest Chemistry Analyzer. IDEXX chemistry analyzer, which uses dry-slide technology, is the veternary industry standard for accuracy, test menu breadth and flexibility, the company says. The new...

  • J&J's Skin Care Brands Interpret New Tech.  // WWD: Women's Wear Daily;2/5/2010, Vol. 199 Issue 25, p6 

    The article reports that Johnson & Johnson is preparing to launch new skin care products using the bioelectricity technology, called Cytomimic. May Shana, vice president of research and development for J&J Beauty Care, said the technology of Cytomimic uses the power of the human body's own inner...

  • Product Briefs.  // Biomedical Business & Technology;Mar2009, Vol. 32 Issue 3, p30 

    The article compares the drug-eluting stent (DES) from Medronic and the Cypher DES from Johnson & Johnson.

  • Antibiotics.  // Formulary;May2006, Vol. 41 Issue 5, p256 

    The article provides product information on newly develop antibiotic drugs in the pharmaceutical industry. Included are the ceftobiprole type IV broad-spectrum cephalosporin antibiotic indicated for treatment of bacterial infection, develop by Basilea Pharmaceutica AG and Johnson & Johnson,...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics